IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into over 100 countries.
MOUNTAIN VIEW, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the third quarter and nine months ended September 29, 2018.
Third Quarter Highlights
Cyclo G6™ product revenue increased approximately 23% year-over-year
Shipped 10,400 G6 probes
Shipped 117 G6 laser systems
Total revenue of $11.3 million
Received FDA Clearance to introduce updated TruFocus LIO Premiere™ Laser Accessory to the U.S. Market
MOUNTAIN VIEW, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in upcoming investor conferences.
IRIDEX’s management is scheduled to present at the Stephens NY Investment Conference on Wednesday, November 7th, 2018 at 4:00 pm Eastern Time.
IRIDEX’s management is scheduled to present at the Stifel Healthcare Conference in New York City on Tuesday, November 13th, 2018 at 3:30 pm Eastern Time.
Interested parties m...
Glaucoma and Retina Specialists Will Discuss the Benefits of MicroPulse® Technology
MOUNTAIN VIEW, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq:IRIX), a leading provider of innovative laser systems in ophthalmology, will be hosting a series of panel discussions at the American Academy of Ophthalmology (AAO) in Chicago, IL on October 27-29, 2018. Twenty-seven leading glaucoma and retina specialists from around the world will highlight how they are using IRIDEX lasers i...
MOUNTAIN VIEW, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the third quarter 2018 after the close of trading on Thursday, November 1, 2018. The Company’s management team will host a corresponding conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET.
Investors interested in listening to the conference call may do so by dialing (844) 707-0665 for domestic callers or (703) 326-3030 for internati...
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.